Max Robotics — Global Service Robot Directory + US Certification

About

Dr. Hiroe Ito is a pioneering gynecologic oncologist whose research focuses on advancing minimally invasive robotic surgery for uterine cancers, including endometrial and cervical malignancies. Her major contributions center on optimizing surgical techniques and evaluating oncological safety. In a pivotal 2022 study (10 citations), Dr. Ito investigated whether using a uterine manipulator during robotic surgery for early-stage endometrial cancer affects disease-free survival, providing critical evidence for surgical best practices. She has also innovated in operative efficiency, demonstrating the feasibility of single-assistant robotic hysterectomy (8 citations) and validating a four-port, no-assistant-port technique for total laparoscopic hysterectomy—advances that reduce surgical team size and costs. Dr. Ito leads a multicenter prospective trial in Japan (2024, 4 citations) assessing robot-assisted radical hysterectomy for cervical cancer, a landmark study shaping national guidelines. Her work has been instrumental in establishing robotic surgery as a safe, effective alternative to open procedures, with cumulative citations exceeding 27. By systematically addressing technical and oncological questions, Dr. Ito has become a key figure in the global adoption of robotic gynecologic oncology, directly improving patient outcomes and surgical accessibility.